Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Clinical trial NCT02254408 · COMPLETED
Trial details
- NCT number
- NCT02254408
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-23
- Primary completion
- 2017-07-14
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.